These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7066167)

  • 21. Standardizing 8-methoxypsoralen plasma profiles by using an emulsion form.
    Van Boven M; Roelandts R; Adriaens P; Daenens P; Degreef H; Kinget R
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):822-7. PubMed ID: 4008686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and longwave ultraviolet light (PUVA).
    Siddiqui AH; Cormane RH
    Br J Dermatol; 1979 Mar; 100(3):247-50. PubMed ID: 435382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of 8-methoxypsoralen 2 hours after oral administration.
    Steiner I; Prey T; Gschnait F; Washüttl J; Greiter F
    Acta Derm Venereol; 1978; 58(2):185-8. PubMed ID: 76402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen.
    Siddiqui AH; Stolk LM; Cormane RH
    Arch Dermatol Res; 1984; 276(5):343-5. PubMed ID: 6486881
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
    Neild VS; Scott LV
    Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.
    Muret P; Humbert P; Makki S; Bechtel P; Urien S; Tillement JP
    Arch Dermatol Res; 1993; 285(5):287-90. PubMed ID: 8379689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy.
    Shephard SE; Langguth P; Panizzon RG
    Photodermatol Photoimmunol Photomed; 2001 Feb; 17(1):11-21. PubMed ID: 11169171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
    Herfst MJ; De Wolff FA
    Eur J Clin Pharmacol; 1982; 23(1):75-80. PubMed ID: 7128674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
    Meffert H; Metz D
    Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
    [No Abstract]   [Full Text] [Related]  

  • 30. 8-Methoxypsoralen serum levels in poor responders to photochemotherapy. Importance of drug formulation and individual factors.
    Walther T; Haustein UF
    Int J Dermatol; 1991 Jul; 30(7):516-8. PubMed ID: 1769779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
    Stern RS; Momtaz K
    Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of 8-methoxypsoralen following oral or bath-water treatment.
    Thomas SE; O'Sullivan J; Balac N
    Br J Dermatol; 1991 Jul; 125(1):56-8. PubMed ID: 1873204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
    Shephard SE; Schregenberger N; Dummer R; Panizzon RG
    Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic comparison of seven 8-methoxypsoralen brands.
    Menne T; Andersen KE; Larsen E; Solgaard P
    Acta Derm Venereol; 1981; 61(2):137-40. PubMed ID: 6165189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
    Ljunggren B; Bjellerup M; Carter DM
    J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mitotic index in psoriatic plaques and their response to PUVA therapy.
    Goldberg LH; Cox AJ; Abel EA
    Br J Dermatol; 1980 Apr; 102(4):401-5. PubMed ID: 7387882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psoriasis phototherapy. Antipsoriatic efficacy of 8-methoxypsoralen and tar baths].
    Rowe E; Meffert H; Miehe M; Sönnichsen N
    Dermatol Monatsschr; 1985; 171(3):180-4. PubMed ID: 3996697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.